Clinical pharmacokinetic and pharmacodynamic studies with the nonclassical antifolate thymidylate synthase inhibitor 3,4-dihydro-2-amino-6-methyl-4-oxo-5-(4-pyridplthio)-quinazolone dihydrochloride (AG337) given by 24-hour continuous intravenous infusion

Publication | Closed Access

Citations

References

1995

Year

Rafi Rafi, Taylor, Calvete, Boddy, Balmanno, Bailey, Lind Lind, Calvert, Webber, Jackson,

Clinical Cancer Research

Medicinal ChemistryMedicineClinical PharmacologyClinical PharmacokineticThyroid HormoneDrug DevelopmentPharmacologyPharmacodynamic Studies